This webinar provided an update on developments in the field relating to content presented at the Advances in Cancer Immunotherapy programs and focused on applicable information for a clinical audience. More specifically, program organizers May Cho, MD, and Terence Rhodes, MD, PhD provided...
Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article identifying appropriate early efficacy metrics predictive of overall survival for immunotherapy trials. Authors: Meihua Wang, Cong Chen , Thomas Jemielita , James Anderson , Xiaoyun (Nicole) Li , Chen...
Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article describing a phase Ib clinical trial evaluating treatment with BI1361849 combined with local radiation in 26 stage IV NSCLC patients with partial response (PR)/stable disease (SD) after standard first-line therapy...
Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article seeking to improve Clinicopathological and molecular features of responders to nivolumab for advanced gastric cancer (AGC). Results show some features were associated with favorable response to nivolumab for AGC....
Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article illustrating that FLT PET uptake was significantly predictive of progression-free survival and the occurrence of adverse events relating to thyroid function. The results suggest FLT PET imaging has potential as a...
Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article providing key clinical data in patients with solid epithelial tumors following treatment with IV enadenotucirev monotherapy and supports further investigation of enadenotucirev in combination with other...
This webinar provided an update on developments in the field relating to content presented at the Advances in Cancer Immunotherapy programs and focused on applicable information for a clinical audience. More specifically, program organizers Christian M. Capitini, MD, and Zachary S. Morris,...
The ASCO-SITC Clinical Immuno-Oncology Symposium is a three-day meeting focused on clinical and translational research in immuno-oncology and the implications for clinical care. This meeting addresses the high-level of need for clinical education in a field where all aspects of care are...
02-28-2019 07:30 - 03-02-2019 16:00 PT San Francisco CA
Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article the PARP inhibitor olaparib was combined with durvalumab to treat mCRPC, regardless of patients’ mutational status. Authors: Fatima Karzai , David VanderWeele , Ravi A. Madan , Helen Owens , Lisa M. Cordes ...
Published in the Journal for ImmunoTherapy of Cancer (JITC), is an update on long-term survival results from two single-arm, phase II adjuvant trials (Trial 3 and Trial 5) with the focus on treatment beyond recurrence of the disease. Authors: Jacek Mackiewicz , Tomasz Burzykowski , Dariusz...
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us